Sign up here to get the latest health & fitness updates in your inbox every week!
The SNAPS eye shield is shown modeled on a mannequin head, while a computer screen shows other shields and a SNAPS prototype in Morgantown W.Va. on Aug. 3, 2022. A team at Intermed Labs in Morgantown learned in July 2021 that the shields on the market aren’t very comfortable or easy to use, and set out to make something better. The result was SNAPS, now in beta testing before going to mass market.
SNAPS CEO Joe Duda, left, Intermed intern Emily Stanton; Intermed design engineer Zac Hoopes; Intermed CEO Tom McClellan pose in Morgantown W.Va. on Aug. 3, 2022. A team at Intermed Labs in Morgantown learned in July 2021 that the shields on the market aren’t very comfortable or easy to use, and set out to make something better. The result was SNAPS, now in beta testing before going to mass market.
MORGANTOWN, W.Va. (AP) — More than 6 million people per year undergo eye surgeries and require an eye shield for protection during the healing process.
A team at Intermed Labs in Morgantown learned in July 2021 that the shields on the market aren’t very comfortable or easy to use, and set out to make something better. The result was SNAPS, now in beta testing before going to mass market.
And it took just a year. “A year in the world of medical devices — unheard of,” said Intermed co-founder and CEO Tom McClellan. “To have a product already on the market from literally a napkin to discussing with a multinational, in my mind, is incredible and is a testament to what is possible here in Morgantown.”
SNAPS CEO Joe Duda explained that eye shields are plastic or other materials but are fixed on the face with tape. They’re needed following cataract, retina, Lasik and reconstruction surgeries.
Taping a shield on poses several problems, he said. It occludes air flow, needed to help healing. It has to be removed to examine the eye or apply medications, which may need to be done several times a day. And existing shields have sharp edges that dig into the skin, causing irritation.
“The unique things about SNAPS,” he said, “is the adhesive anchors that are used.” They’re modeled after cardiac leads, but smaller. No tape is needed. SNAPS is transparent and has air holes and is easily hinged open and rotated for an exam or medication application. And it sits up just off the skin so it doesn’t dig in or irritate.
McClellan described how SNAPS got started. “When doctors have ideas, they don’t necessarily have the time, money or expertise to make those ideas come to fruition, or they don’t have the ability to pivot off those ideas to make them better.”
In this case, Intermed was approached by a retina surgeon in Sarasota, Florida, who had trouble with current eye shields and had an idea that technically wasn’t good, McClellan said. But they started to do market research and saw that the shield issue is a bigger problem and could be a low-hanging fruit for problem solving.
So they got Intermed together to figure out how to improve standard eye shields considering ease of manufacturing and market constraints — price and production cost.
A photo of a SNAPS prototype shows the developmental model was gray, being 3D printed there on the top floor. It went through multiple iterations to perfect the shape, size, connections. Intermed has a deep medical bench, McClellan said, through its partnership with Mon Health, and they consulted with physicians for suggestions and feedback.
They considered using magnets for connectors, Duda said, but that was a no-go because of patient aversion to the magnets. That led to using the adhesive tabs modeled after cardiac leads. A patient will wear a shield anywhere from a day to a couple weeks, depending on the procedure performed. So their testing included showering with SNAPS on and other trials to make sure the tabs stick.
Once they had the design they wanted, the final version was injection molded.
The version they’ve shipped for beta testing is medical grade polycarbonate. It’s transparent but strong, Duds said. The anchors flex but don’t break.
Beta testing will last about three months, McClellan said.
Production volume is in the thousands at the moment, McClellan said, but with 6 million shields per year in use, “clearly this has room to ramp up.” They recently talked with a multinational marketing and sales organization interested in partnering with them.
Duda is a Morgantown native who recently moved to Winchester, Va. He is a pharmacist and MBA who worked at Mylan/Viatris and left that company in April 2020.
After leaving Viatris, he said, he was connected with McClellan. “It sounded like a very interesting, grass-roots opportunity, very boutique.” They come in with an idea, sit around a table and get something done quickly — unlike at a bigger company that moves more ponderously.
Intermed design engineer Zac Hoopes was recruited from Pennsylvania. He said he was involved in the early design phase of SNAPS — testing, materials, 3D printing — but other engineers then took over. He’s heading up another Intermed project.
Intern Emily Stanton is a UHS junior recruited in late July who is also developing her own project making prototypes based on her original ideas.
Stanton’s internship led McClellan to talk about his vision for Intermed. “If we can attract talent like this who stay locally and then continue to work for us,” he said, “and they spin off products to create revenue to hire them. Do you see the ecosystem we’re starting to build?
“This is a very unique place,” he said. “My singular goal for the rest of my life is to attract talent like this to West Virginia.”
They want to fill up the entire floor, 12,000 square feet, with engineers and design space, McClellan said.
“That’s why we’re so excited to be partners with Mon Health, and hopefully very soon CAMC in Charleston, and service the 5,000 doctors and 20,000 nurses in the state that have amazing ideas that can help patients. We can do all of that right here.”
For copyright information, check with the distributor of this item, The Dominion Post.
Sign up here to get the latest health & fitness updates in your inbox every week!
Hives are an allergic reaction and can sometimes be a sign of a more serious immune response.
Millions of Americans will be able to buy hearing aids without a prescription later this fall, under a long-awaited rule finalized Tuesday.
THURSDAY, Aug. 11, 2022 (HealthDay News) -- For people with multiple sclerosis, certain factors early in their disease may determine their quality of life in the years to come, a new study suggests.
A fall can cause something as minor as a scraped knee or as catastrophic as a broken bone. One way to minimize injury is to have strong fingers and hands.
Here are some tried-and-true tips from experts on how to ease those "please-let-me-get-to-sleep" worries.
Men are known to be more likely to develop cancer than women, and a new study suggests that this is due to certain biologic differences between the sexes. Here's that and more health news.
Georgia’s governor has high hopes for his alma mater. Atlanta is set to become the first two-time host of college football’s national championship game in 2025. Governor Brian Kemp sees no reason the Georgia Bulldogs can’t be going for their fourth straight title when the game returns to the A-T-L. Atlanta is reveling in its selection as a repeat host, boasting that it has everything needed to pull off another thrilling event. It previously hosted in 2018, less than a year after the opening of its 75,000-seat, retractable roof stadium. Alabama beat Georgia in overtime that year.
It’s not just mosquitos. Flooding, extreme heat and other climate-related hazards are bringing people into contact with pathogens more often.
A New England Journal of Medicine study has given rise to a catchphrase for a kind of medical caregiver-to-community interaction: “retail-based” health care.
U.S. regulators have finalized a long-awaited rule that's expected to allow millions of Americans to buy hearing aids without a prescription. The rule announced Tuesday by the Food and Drug Administration goes into effect this fall. It creates a new class of hearing aids that don’t require a medical exam, a prescription and other specialty services. Instead the devices will be sold online or over-the-counter at pharmacies and other retail stores. The move follows years of pressure from medical experts and consumer advocates to make the devices cheaper and easier to get. Devices for more severe hearing loss will remain prescription only.
The SNAPS eye shield is shown modeled on a mannequin head, while a computer screen shows other shields and a SNAPS prototype in Morgantown W.Va. on Aug. 3, 2022. A team at Intermed Labs in Morgantown learned in July 2021 that the shields on the market aren’t very comfortable or easy to use, and set out to make something better. The result was SNAPS, now in beta testing before going to mass market.
SNAPS CEO Joe Duda, left, Intermed intern Emily Stanton; Intermed design engineer Zac Hoopes; Intermed CEO Tom McClellan pose in Morgantown W.Va. on Aug. 3, 2022. A team at Intermed Labs in Morgantown learned in July 2021 that the shields on the market aren’t very comfortable or easy to use, and set out to make something better. The result was SNAPS, now in beta testing before going to mass market.
Get up-to-the-minute news sent straight to your device.